Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Stormer

This article was originally published in The Gray Sheet

Executive Summary

Balloon angioplasty catheter with Zipper delivery platform technology gains FDA approval via PMA supplement. A simultaneous CE mark includes use for stent delivery. The "multi-exchange" technology offers benefits of both over-the-wire and rapid-exchange platforms, according to Medtronic. The device permits use of a short guidewire, enables guidewires to be changed without removing the catheter from the body and allows catheters of different sizes to be exchanged during a procedure. Medtronic expects the platform to be available in the U.S. with a variety of catheters, balloons and stents by year-end...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT017225

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel